...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: The cardiac pre-print now published....in Cell!

As RVX has no track record in infectious diseases there's no possibility they will have much say in the design of the covid trial. It will be designed by experts.

What's more a trial of this type will cost peanuts compared with something like BoM. So we don't have to worry about that either.

We can sleep!

Share
New Message
Please login to post a reply